6/2/2009 Standard Report Set

BioPharm Insight - Powered by Infinata (www.biopharminsight.com)

Email This Report Export to Excel Printer Friendly Version

BioPharm Clinical Trial Enrollments from May 2009

This report prov ides links to exciting new drug dev elopments in the Biotech, Pharmaceutical, and Drug Deliv ery Industries. Please click on any of the links for more details.

To schedule a demonstration of BioPharm Insight, click here or call 1-781-702-6938.

Clinical Trial Enrollments

Date New s ID Company Name Industry Type of New s Indication Trade Name
2009-05-29 69125 Baye r He althcare LLC P harm a ce utical Phase III Initia te d Liver C ancer Ne x avar w/ Tarceva
2009-05-29 69166 Inte rce ll AG Biote ch Phase II Initiate d Influe nza Inte rce ll Pa n. Flu Vaccine P atch
2009-05-29 69157 Incyte C orpora tion Scie ntific Re se arch & De ve lopm e nt Se rvice s Phase III Ente re d He m ato logical (Ge ne ra l) INCB18424
2009-05-29 69121 O nyx P harm a ce uticals, Inc. P harm a ce utical Phase III Initia te d Liver C ancer Ne x avar w/ Tarceva
2009-05-29 69155 Am a rillo Bioscie nce s Biote ch Phase II Initiate d Influe nza Am arillo Inte rfe ron Alpha (O ral Lo w Dose )
2009-05-28 69064 C ornerstone Pharm a ce uticals P harm a ce utical Phase I/II Initiate d Pa ncrea tic C ancer CP I-613
2009-05-28 69088 Ne oprobe C orporatio n Me dical De vice s and Equipm e nt Phase III Initia te d He ad and Ne ck C ance r Lym phose e k
2009-05-27 69024 Ve rte x Pha rm ace utica ls, Inc. Biote ch Phase III Initia te d C ystic Fibrosis VX-770
2009-05-27 69037 Fa te The rape utics Diagnostics - The rape utics Phase I Initiate d He m ato logical Ca nce r Sm all Mo le cule Ste m Ce ll Modulator
2009-05-27 69038 Me dare x , Inc. Biote ch Phase I Ente re d Le uk e m ia MDX-1338
2009-05-26 68976 Vax a rt, Inc. (FKA: W e st C oa st Biologica ls) Biote ch Pre -Clinica l Initia te d Influe nza Vax art H1N1 Influe nza Va ccine
2009-05-26 68981 Nano viricide s, Inc Biote ch Pre -Clinica l Ente re d Influe nza FluC ide
2009-05-24 68946 Bioniche Life Scie nce s P harm a ce utical Phase III Initia te d Bla dde r C ance r Urocidin
2009-05-22 68938 Dr. R e ddy'S La borato rie s Lim ite d P harm a ce utical Phase I Initiate d Athe roscle ro sis DR L 17822
2009-05-21 68878 Am a rillo Bioscie nce s Biote ch Phase II Ente re d Influe nza Am arillo Inte rfe ron Alpha (O ral Lo w Dose )
2009-05-21 68890 P olym e dix Inc Biote ch Phase I Initiate d Staphylococcus Aure us Infe ction PMX-30063
2009-05-21 68894 Eli Lilly & Co . P harm a ce utical Phase III Initia te d Alzhe im e rs Dise ase Sola ne zum a b
2009-05-20 68925 Ge nta Inco rpo rated Biote ch Phase III Initia te d Mela nom a Ge nase nse w/ Dacarbazine
2009-05-19 68809 Inte lge nx Co rp P harm a ce utical Se rvice s Phase I Ente re d Hype rlipide m ia /Dyslipide m ia CR ES Pra vasta tin
2009-05-19 68790 Ge nta Inco rpo rated Biote ch Phase III Initia te d Mela nom a Ge nase nse w/ Dacarbazine
2009-05-19 68854 Abbo tt Labo ratorie s P harm a ce utical Phase III Initia te d C onstipation AMITIZA
2009-05-19 68763 Ve nus R e m e die s, Ltd. P harm a ce utical Phase III Initia te d Bronchitis Nove l Inje cta ble Am inoglyco side
2009-05-19 68786 Age nnix , Inc. Biote ch Phase III Initia te d Lung C ance r Tala ctofe rrin Alfa
2009-05-19 68765 R e x ahn Pharm ace uticals P harm a ce utical Phase II Initiate d De pre ssion/Stre ss/Anx ie ty Se rdax in
2009-05-19 68804 C irc P harm a , Ltd. Biote ch Phase I Ente re d Hype rlipide m ia /Dyslipide m ia CR ES Pra vasta tin
2009-05-19 68764 Ve nus R e m e die s, Ltd. P harm a ce utical Phase III Initia te d Ba cte ria l Infe ctions Nove l Inje cta ble Am inoglyco side
2009-05-19 68855 Sucam po Pha rm ace utica ls, Inc. P harm a ce utical Phase III Initia te d C onstipation AMITIZA
2009-05-18 68762 Ste m C e ll The rape utics Co rp. (Sct) Biote ch Phase II Initiate d Strok e NTx -265
2009-05-18 68723 Entre m e d, Inc. Biote ch Phase I Initiate d Le uk e m ia ENMD-2076
2009-05-18 68814 Novava x , Inc. Biote ch Phase II Initiate d Influe nza Triva le nt flu VLP Va ccine
2009-05-15 68611 Apre a AB Biote ch Phase I Ente re d Hem ato logical Ca ncer APR -246
2009-05-15 68649 Ste m C e ll The rape utics Co rp. (Sct) Biote ch Phase II Initiate d Strok e NTx -265
2009-05-15 68618 Diam yd Me dical P harm a ce utical Phase III Initia te d Diabe te s (Type 1) Dia m yd
2009-05-15 68654 Novava x , Inc. Biote ch Phase II Initiate d Influe nza Triva le nt flu VLP Va ccine
2009-05-15 68610 Apre a AB Biote ch Phase I Ente re d Prosta te Ca nce r APR -246
2009-05-15 68699 Nile The rape utics, Inc. P harm a ce utical Phase II Ente re d He art Fa ilure Chim e ric Na triure tic Pe ptide
2009-05-14 68564 Ste m C e ll The rape utics Co rp. (Sct) Biote ch Phase II Initiate d Strok e NTx -265
2009-05-14 68599 Eryte ch Pha rm a Biote ch Phase II Initiate d Le uk e m ia GR ASPA
2009-05-14 68573 P rove ctus P harm a ce uticals P harm a ce utical Phase II Initiate d Me la nom a Pro ve cta
2009-05-14 68600 Via P harm a ce uticals, Inc. P harm a ce utical Phase II Initiate d Acute C orona ry Syndrom e VIA-2291
2009-05-14 68602 Alpha vax , Inc. Biote ch Phase I/II Initiate d C olore ctal Ca nce r CEA(6D)-VR P Im m unothe rapy
2009-05-14 68604 Mo le cular Insight P harm a ce uticals (FKA: Bio stre am ) P harm a ce utical Phase III Ente re d Gastrointestinal C ance r O nalta
2009-05-13 68544 Ne rvia no Me dical Scie nces P harm a ce utical Phase I Ente re d C ance r (Ge neral) Nerviano PLK1 Inhibito r
2009-05-13 68535 Alk e rm e s, Inc. P harm a ce utical Phase I Initiate d Alcohol/Drug De pe nde nce ALKS 33

infinata5.com/biopharm/AccessPoint.aspx?action=… 1/1